After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Phathom Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Phathom Pharmaceuticals Inc is $830.75M. A total of 1.2 million shares were traded on the day, compared to an average of 1.10M shares.
In the most recent transaction, Breedlove Robert Charles sold 461 shares of PHAT for 12.09 per share on Sep 05 ’25. After the transaction, the Principal Accounting Officer now owns 47,931 company shares. In a previous transaction on Jul 16 ’25, Breedlove Robert Charles sold 1,692 shares at 8.36 per share. PHAT shares that Principal Accounting Officer owns now total 48,392.
Among the insiders who bought shares, Topper James N acquired of 3,780 shares on May 21 ’25 at a per-share price of $3.86. This resulted in the Director holding 59,403 shares of PHAT after the transaction. In another insider transaction, Topper James N bought 6,300 shares at $3.32 per share on May 14 ’25. Company shares held by the Director now total 55,623.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, PHAT has a high of $19.50 and a low of $2.21.
As of this writing, PHAT has an earnings estimate of -$0.44 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.3 per share and a lower estimate of -$0.67. The company reported an EPS of -$1.05 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. PHAT’s latest balance sheet shows that the firm has $183.26M in Cash & Short Term Investments as of fiscal 2021. There were $91.34M in debt and $18.92M in liabilities at the time. Its Book Value Per Share was -$5.79, while its Total Shareholder’s Equity was $72.16M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PHAT is Buy with a score of 4.44.
